You React to Chemicals Others Don't. Your Genes May Be Why.

GSTM1 is one of your body’s primary detoxification enzymes. It works by conjugating toxins with glutathione, a molecule that makes poisons water-soluble so your kidneys and liver can eliminate them. Without GSTM1, large classes of environmental chemicals get stuck in your tissues longer.

Roughly 50% of people carry a GSTM1 null genotype, meaning the gene is completely deleted. If you’re one of them, you have zero copies of the GSTM1 enzyme. You cannot conjugate and clear entire categories of environmental toxins efficiently, no matter how hard you try. Pesticides, solvents, and heavy metals linger in your system much longer than they do in people with intact GSTM1.

The result: after exposure to pesticides, paint fumes, or cleaning products, you don’t recover as quickly. Your headaches last longer. Your fatigue goes deeper. You become progressively more sensitized because the toxins are accumulating in your tissues rather than being cleared.

GSTP1 is a second phase II detox enzyme, focused on clearing oxidative stress byproducts and reactive oxygen species generated by your mitochondria and by exposure to pollutants. It’s especially critical when you’re exposed to heavy metals, persistent organic pollutants, or chemical oxidizers.

The Ile105Val variant (Val allele), carried by roughly 35-40% of people, reduces GSTP1 enzyme activity. People with Val alleles clear oxidative stress byproducts more slowly, allowing free radicals and lipid peroxides to accumulate in tissues. This is especially problematic if you also have impaired SOD2 or MTHFR variants, because the damage compounds.

You notice this as persistent inflammation even on low-chemical days, brain fog that won’t lift, joint pain or muscle aches that seem disproportionate to activity, and a sense that your body never quite recovers from exposures the way other people’s do.

CYP1A2 is a phase I enzyme. Phase I enzymes transform lipid-soluble toxins into intermediate forms that phase II enzymes can then conjugate and eliminate. CYP1A2 specifically handles environmental chemicals called aryl hydrocarbons, which come from traffic exhaust, grilled meat, and pesticide residues.

High-activity variants of CYP1A2 (especially in fast metabolizers) activate these toxins into reactive intermediates very quickly. If your phase II enzymes like GSTM1 or GSTP1 are slow, your CYP1A2 creates a backlog of toxic intermediates that overwhelm your conjugation capacity. Roughly 35-40% of people have reduced CYP1A2 activity, creating a slower phase I transformation.

You experience this as sensitivity to grilled or charred foods, pronounced reactions to air pollution during high-traffic days, and an inability to tolerate the chemical byproducts of cooking at high heat. Your symptoms worsen in cities or near highways.

MTHFR is the enzyme that activates folate into its bioactive form, which then drives methylation throughout your body. One of methylation’s critical jobs is producing glutathione, your master antioxidant and phase II detox cofactor. MTHFR also supports the production of SAM-e, which drives heavy metal binding and elimination.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme activity by 35-40%. If you carry this variant, you produce less glutathione and less SAM-e, which means you have less raw material for heavy metal detoxification and oxidative stress management. This bottleneck cascades into every detox pathway downstream.

You feel this as compounding fatigue after chemical exposure, persistent heavy metal toxicity symptoms (brain fog, tremors, numbness) that don’t respond to general detox, and slow recovery from multiple simultaneous exposures. You may also notice your mood destabilizes more easily during high-exposure periods.

SOD2 is the primary antioxidant enzyme inside your mitochondria, where the damage from chemical exposures and oxidative stress accumulates fastest. Every toxin your cells try to process generates free radicals. SOD2 neutralizes them before they damage your mitochondrial DNA. Without sufficient SOD2 activity, mitochondrial damage accelerates.

The Val16Ala variant, present in roughly 40% of people with European ancestry, reduces SOD2 protein efficiency. People carrying the Ala allele accumulate oxidative damage inside their mitochondria faster, especially when exposed to environmental toxins, heavy metals, or air pollution. This is particularly damaging because mitochondrial damage impairs energy production directly.

You notice this as rapid fatigue with chemical exposure, a sensation of your energy crashing disproportionately to the level of exposure, post-exertional malaise (feeling worse after minimal activity), and persistent low energy even on days you manage to avoid chemicals. Your recovery from illness is slower than it should be.

NQO1 is a specialized phase II enzyme that processes quinones, which are produced when your body breaks down certain environmental chemicals like benzene and polycyclic aromatic hydrocarbons. NQO1 also neutralizes reactive byproducts from pesticides and air pollution. It’s your first line of defense against many occupational and urban exposures.

The Pro187Ser null variant, present in 4-20% of the population depending on ancestry, eliminates NQO1 activity entirely. People with NQO1 null variants cannot process benzene or quinone-containing chemicals efficiently, which means these toxic intermediates accumulate in tissues and organs. This is especially problematic for people living near highways, gas stations, or in areas with heavy traffic.

You experience this as acute reactions to car exhaust, sensitivity to gasoline fumes, strong reactions to certain pesticides, and inability to tolerate foods stored in pesticide-heavy environments. Your symptoms cluster around traffic-related exposures and chemical processing facilities.